These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4157594)

  • 1. [On the efficacy of conjugated estrogens in therapy of bladder retention due to prostatic hypertrophy].
    Giannoni R; Zini S
    Friuli Med; 1964; 19(6):1033-47. PubMed ID: 4157594
    [No Abstract]   [Full Text] [Related]  

  • 2. [Exogenous estrogens and the urinary tract].
    Grio R; Pagliano M; Bongiovanni A; Boggio GF; Alessandri A; Carbone G
    Minerva Ginecol; 1986 Jun; 38(6):503-5. PubMed ID: 3016610
    [No Abstract]   [Full Text] [Related]  

  • 3. [Conservative therapy of prostatic hyperplasia with urinary retention].
    Djulepa J
    Med Welt; 1983 Dec; 34(48):1377-9. PubMed ID: 6197601
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of therapy with progesterone in micturition disturbances due to prostatic hypertrophy].
    Cucinotta D; Passeri M
    Minerva Med; 1972 Apr; 63(27):1583-600. PubMed ID: 4112960
    [No Abstract]   [Full Text] [Related]  

  • 5. [Influence of gestagens on the symptoms of prostatic hypertrophy].
    Graber P; Leibundgut B
    Urologe A; 1972 Nov; 11(6):326-9. PubMed ID: 4118967
    [No Abstract]   [Full Text] [Related]  

  • 6. [Generally effective for unstable bladder? Tamsulosin: application not limited to benign prostatic hyperplasia].
    Urologe A; 2003 Feb; 42(2):301-2. PubMed ID: 12739514
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical application of "PPC" to prostatic hypertrophy and others].
    Sugiura H; Shimaya M
    Hinyokika Kiyo; 1969 Jun; 15(6):450-3. PubMed ID: 4185864
    [No Abstract]   [Full Text] [Related]  

  • 8. Anticholinergic therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia.
    Gallegos PJ; Frazee LA
    Pharmacotherapy; 2008 Mar; 28(3):356-65. PubMed ID: 18294115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug treatment of prostatic hypertrophy].
    Sökeland J; Bressel M
    Dtsch Med Wochenschr; 1966 Nov; 91(44):1982-4. PubMed ID: 4163463
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of hypertrophy of the prostate with gestagens].
    Vahlensieck W; Gödde S
    Munch Med Wochenschr; 1968 Jun; 110(26):1573-7. PubMed ID: 4182927
    [No Abstract]   [Full Text] [Related]  

  • 11. [Phenoxybenzamine in prostatic pathology. 300 cases (author's transl)].
    Lardennois B; El Khansa A; Amory JP; Coulon JM; Lemaire P
    J Urol (Paris); 1981; 87(4):243-8. PubMed ID: 6167646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Benign prostatic syndrome. Urinary urgency and micturition frequency reduced with plant preparation].
    MMW Fortschr Med; 2005 Oct; 147(40):52-3. PubMed ID: 16255520
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prostatilen effects on voiding disorders in patients with benign prostatic hyperplasia].
    Al'-Shukri SKh; Gorbachev AG; Borovets SIu; Belousov VIa; Kuz'min IV
    Urologiia; 2005; (5):25-6. PubMed ID: 16281835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic variables: novel and perhaps better predictors of progression in benign prostatic hyperplasia.
    Armitage JN; Emberton M
    BJU Int; 2006 Mar; 97(3):439-41. PubMed ID: 16469003
    [No Abstract]   [Full Text] [Related]  

  • 15. [Conservative therapy of prostate adenoma with phenoxybenzamine. Clinical aspects and urodynamics].
    Flamm J
    Fortschr Med; 1981 Nov; 99(43):1820-2. PubMed ID: 6171493
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of urination disorders with Raveron].
    Ichim V
    Z Urol Nephrol; 1970 Apr; 63(4):255-60. PubMed ID: 4109019
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the effects of oral administration of medroxyprogesterone acetate on urination disorders due to prostatic hypertrophy].
    Valentino RV; Alberti C
    Recenti Prog Med; 1969 Sep; 47(3):XXI-XXXV. PubMed ID: 4099290
    [No Abstract]   [Full Text] [Related]  

  • 18. [The action of different forms of hormone therapy in prostatic adenoma].
    Délivéliotis A; Rodis N
    J Urol Nephrol (Paris); 1968 Mar; 74(3):211-22. PubMed ID: 4171642
    [No Abstract]   [Full Text] [Related]  

  • 19. [Medroxyprogesterone acetate in urinary retention caused by inoperable prostatic hypertrophy].
    Menozzi D; Debbia F
    Minerva Urol; 1970; 22(3):89-105. PubMed ID: 4099514
    [No Abstract]   [Full Text] [Related]  

  • 20. [Kampo preparations for prostatic hyperplasia: usefulness of Saireito for nocturia].
    Sugiyama T; Oonishi N; Onoe M; Kurita T
    Hinyokika Kiyo; 2002 Jun; 48(6):343-6. PubMed ID: 12166233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.